The AI Capex Paradox: Why Chips Rally While Software Crumbles at Midday

The Market's Uncomfortable Truth: AI Spending Isn't Creating Winners Evenly

Stocks closed near all-time highs Monday while bond yields fell after weaker-than-estimated retail sales reinforced the case for the Federal Reserve to cut interest rates this year. But Tuesday's midday action reveals a market fracturing along a critical fault line: semiconductor strength masking a deepening crisis in enterprise software.

The Dow Jones Index is up 0.79% Tuesday, with top gainers including Walt Disney (2.56%), American Express (2.24%), and Salesforce (2.09%), while Amgen (-1.31%), Coca-Cola (-0.86%), and Merck (-0.73%) led declines. Yet beneath these headline movers lies a sector rotation that threatens the entire AI investment thesis.

Chips Soar on Demand Signals, But Software Faces Existential Threat

Chip producers were higher with Nvidia, AMD, and Broadcom adding close to 1% following strong orderbooks posted by TSMC during January. This strength reflects sustained confidence in AI infrastructure spending. At the low end of capex guidance, the four major cloud companies would spend about $635 billion this year, marking a roughly 67% spike from 2025's $381 billion expenditures, with potential high-end spending around $665 billion, or a 74% jump.

But here's the problem: An ETF tracking software firms extended a three-day advance to 8.5%, but chipmakers fell following a solid run. Investors are increasingly asking whether massive capex translates to software value. Near-term profitability won't be enough for many software companies in 2026, as they live under the threat that AI will render their special sauce not so special, while AI companies have gotten a pass on profitability but will face increased pressure to show profits and eat into software territory, pressuring software company boardrooms toward sales at less than stellar premia.

Healthcare's M&A Momentum Continues Amid Sector Rotation

Coca Cola fell over 3% after missing fourth quarter revenues, while CVS lost more than 1% after delivering lower-than-expected projections for this year. The consumer staples weakness contrasts sharply with healthcare's strategic repositioning. Technology led megadeal activity in 2025 with 26 announced deals, banking followed with 13, and manufacturing ranked third with 11, as technology is expected to continue attracting the highest deal values in 2026, supported by large-scale investment in AI, data, and digital infrastructure.

The Institutional Divergence: Who's Buying What

Small caps have hit all-time highs, outperforming large cap indexes this year, with the Russell 2000 higher by more than 8%, while the higher quality S&P Small Cap 600 is up by 10%. BTIG's Jonathan Krinsky said he expects small-cap leadership to continue, pointing out that the Mag7 ETF has broken key relative support while the broader market has outperformed as investors rotate out of megacap tech, with small-cap leadership being a new and sustainable trend for 2026.

The Bottom Line: Capex Doesn't Equal Profit

Tuesday's midday market tells an uncomfortable story: US equities inched higher Tuesday, holding gains from the last two sessions as markets continued to gauge AI capital expenditure signals, while pessimistic retail sales data drove rate traders to increase positions on more than two Federal Reserve rate cuts this year. The question haunting investors isn't whether AI is transformative—it's whether the trillion-dollar capex cycle will generate returns proportional to the spending.

Chip stocks are betting yes. Software stocks are pricing in no. The midday action suggests the market is finally choosing sides.